| scholarly article | Q13442814 |
| P50 | author | Yago Pico de Coaña | Q56882779 |
| Felix L Fennemann | Q61467541 | ||
| Jeroen Melief | Q92741115 | ||
| P2093 | author name string | Johan Hansson | |
| Rolf Kiessling | |||
| Maria Wolodarski | |||
| Roeltje Maas | |||
| P2860 | cites work | Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab | Q44017442 |
| Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors | Q44636591 | ||
| Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins | Q45171571 | ||
| Expression and prognostic value of Id protein family in human breast carcinoma. | Q51594374 | ||
| Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2 | Q64008443 | ||
| Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway | Q70142225 | ||
| Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival | Q73393187 | ||
| Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
| Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer | Q80404832 | ||
| alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity | Q80516665 | ||
| VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis | Q87199907 | ||
| Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity | Q88035142 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
| Id proteins: small molecules, mighty regulators | Q28248534 | ||
| Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway | Q28567314 | ||
| BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3 | Q29614624 | ||
| The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells | Q33675431 | ||
| Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes | Q34016867 | ||
| S100A9 a new marker for monocytic human myeloid-derived suppressor cells. | Q34150479 | ||
| ID1 promotes breast cancer metastasis by S100A9 regulation | Q34177858 | ||
| Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers | Q34692406 | ||
| Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation | Q35579455 | ||
| Transcriptional regulation of myeloid-derived suppressor cells | Q36322351 | ||
| Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. | Q36569202 | ||
| Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma | Q36610637 | ||
| The multiple roles of Id-1 in cancer progression | Q36687439 | ||
| Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. | Q36967364 | ||
| Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions | Q37081977 | ||
| S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway | Q37331858 | ||
| Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments | Q37350374 | ||
| On the armament and appearances of human myeloid-derived suppressor cells | Q38031742 | ||
| Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. | Q38532400 | ||
| Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. | Q38672403 | ||
| Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production. | Q39201935 | ||
| mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway | Q39556022 | ||
| Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells | Q39584588 | ||
| Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function | Q39896275 | ||
| Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer | Q39996269 | ||
| Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab | Q41469907 | ||
| Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma. | Q43827746 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 513-522 | |
| P577 | publication date | 2020-01-17 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma | |
| P478 | volume | 69 |
Search more.